Leunca (Solanum nigrum L.) Herbs Ethanolic Extract Increase Cytotoxic Activity of Cisplatin on Hela Cervical Cancer Cells

Raditya Prima Istiaji, Maya Fitria, Larasati Larasati, Fortunella Tjondro, Astrid Ayu Maruti, Erna Prawita Setyowati, Edy Meiyanto


Cervical cancer is one of leading causes of cancer death in women in the developing countries. The use of cisplatin as chemotherapy agent in cervical cancer is known to cause side effects and also resistance for long-term uses. One of the strategies to prevent cervical cancer based on combination agents is being developed. Leunca (Solanum nigrum L.) has been revealed to inhibit growth of human cancer cells. Therefore, it can be used in combination with cisplatin to reduce those side effects and prevent the occurrence of cell resistance. Ethanolic extract of Leunca Herb (ELH) and cisplatin were tested their cytotoxic effect on HeLa cervical cancer cell by using MTT assay to determine IC50 value. The combinationss of cisplatin-ELH were tested to determine the combination index (CI value). The IC50 of ELH and cisplatin on HeLa cells were 227 µg/mL and 17 µM. rRespectively. Tthe study of combination resulted that almost all the index combinations were <0,9 showed the effect of synergism combination. The Ooptimum concentration of combination was 1/8 IC50 cisplatin–1/8 IC50 ELH. The results indicated that ELH had a potency to be combination agent to enhance the activity of cisplatin on HeLa cervical cancer cells. Therefore, further study on its molecular mechanism needs to be explored.


Key words: Leunca (Solanum nigrum L.), cisplatin, cytotoxic, combination agent, HeLa cells

Full Text:



Cepeda, V., Miguel A. F., Josefina C., Carlos Alonso, Celia Q., and Jose M. P., 2007, Biochemical Mechanisms of Cisplatin Cytotoxicity, Anti-Cancer Agents in Medicinal Chemistry, 7(3): 3-18.

Doyle, A. and Griffiths, J.B., 2000, Cell and Tissue Culture for Medical Research, John Willey and Sons Ltd., New York.

Fuertes M.A., Alonso C., and Perez J.M. 2003. Biochemical modulation of Cisplatin mechanisms of action: enhancement of antitumor activity and circumvention of drug resistance. Chem Rev.103:645-62.

Hanahan, D., and Weinberg, R.A., 2000, The Hallmarks of Cancer, Cell, 100:57-70.

Hu K., Kobayashi H., Dong A., Jing Y., Iwasaki S., and Yao X. 1999. Antineoplastic agents. III: Steroidal glycosides from Solanum nigrum. Planta Med. 65(1):35-8.

Ji Y.B., Gao S.Y., Ji C.F., and Zou X. 2008. Induction of apoptosis in HepG2 cells by solanine and Bcl-2 protein. J Ethnopharmacol 115(2):194-202.

Liu LF, Liang CH, Shiu LY, Lin WL, Lin CC, and Kuo KW. 2004. Action of Solamargine on Human Lung Cancer Cells-Enhancement of The Susceptibility of Cancer Cells to TNFs. FEBS Lett. 577(1-2):67-74.

Liu. Yi, Rui Wang, Gen-Quan Qiu, Ke-Jun Nan, and Xi-Cai Sun, 2006, Inhibitory effect of Fuzheng Yiliuyin in Combination with Chemotherapeutics on Human Gastric Carcinoma Cell Strain, World J Gastroenterol 12(25): 4071-4073.

Padanilam, B.J., 2003, Cell Death Induced by Acute Renal Injury: A Perspective on the Contributions of Apoptosis and Necrosis, Am J Physiol Renal Physiol. 284:F608–F627.

Reynolds and Maurer, 2005, Evaluating Response to Antineoplastic Drug Combination in Tissue Culture Models in Methods in Molecular Medicine, vol. 110, Humana Press inc., Totowa, NJ.

DOI: http://dx.doi.org/10.14499/indonesianjcanchemoprev1iss1pp32-37

Copyright (c) 2017 Indonesian Journal of Cancer Chemoprevention

Indexed by:





Indonesian Society for Cancer Chemoprevention